Specific competitive inhibition of L-asparaginyl transfer ribonucleic acid lygase by. beta.-aminoamides
TO Yellin, MR Harnden
Index: Harnden; Yellin Journal of medicinal chemistry, 1970 , vol. 13, # 6 p. 1095 - 1098
Full Text: HTML
Citation Number: 1
Abstract
The introduction of the enzyme L-asparaginase (L-:~ sparagine amidohydrolase) into clinical trials has been the most dramatic development in the treatment of leukemia in recent years. The ultimate usefulness of this enzyme has yet to be determined but the initial results
Related Articles:
[Walborsky; Schwarz Journal of the American Chemical Society, 1953 , vol. 75, p. 3241]
[Walborsky; Schwarz Journal of the American Chemical Society, 1953 , vol. 75, p. 3241]
[Walborsky; Schwarz Journal of the American Chemical Society, 1953 , vol. 75, p. 3241]
[Walborsky; Schwarz Journal of the American Chemical Society, 1953 , vol. 75, p. 3241]
[Walborsky; Schwarz Journal of the American Chemical Society, 1953 , vol. 75, p. 3241]